4 completed, 1 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Exenatide Injection: new trials by email Literature Review of Exenatide Injection trials Research Report on Exenatide Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of EXenatide in Acute Ischaemic Stroke Exenatide Injection - Acute Ischemic Stroke | Phase 2 | Unknown | Neuroscience Trials Australia | 350 | 2017-11-23 | 2021-09-14 |
| Effect of Exenatide on Cortisol Secretion Exenatide Injection - Healthy | Phase 4 | Completed | University of Tartu | 10 | 2017-09-07 | 2018-05-03 |
| Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection Bexagliflozin, Exenatide Injection - Type2 Diabetes Mellitus | Phase 1 | Completed | Theracos | 20 | 2017-05-24 | 2021-05-28 |
| Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients exenatide injection, Mixed Protamine Zinc Recombinant Human Insulin Lispro 25R, Pioglitazone - Diabetes Mellitus, Type 2, Newly Diagnosed | Not applicable | Completed | Sun Yat-sen University | 416 | 2010-08-01 | 2013-08-21 |
| Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus ITCA 650, Exenatide Injection, Ex Inj/ITCA 650 - Type 2 Diabetes | Phase 2 | Completed | Intarcia Therapeutics | 155 | 2009-08-01 | 2015-04-13 |
Diabetes Mellitus, Type 2 (2) · Ischemic Stroke (1) · Stroke (1)
Intarcia Therapeutics (1) · Neuroscience Trials Australia (1) · Sun Yat-sen University (1) · Theracos (1) · University of Tartu (1)
United States (2) · Australia (1) · China (1) · Estonia (1) · Finland (1) · New Zealand (1)
Christopher Bladin (1) · Jianping Weng, Doctor (1) · Mason Freeman, M.D. (1) · Vallo Volke, MD,PhD (1)
PMID 23645886, PMID 36800161, PMID 38011235
2018 (1)